INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Centene Corp. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Centene Corp. ("Centene" or the "Company") (NYSE: CNC). Investors who purchased or otherwise acquired shares between April 26, 2016 and September 6, 2016 inclusive (the "Class Period") are encouraged to contact the firm in advance of the January 13, 2017 lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm's website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The complaint alleges that during the Class Period, Centene made materially false and misleading statements concerning the acquisition of Health Net, Inc. on March 24, 2016, as well as failed to disclose: that certain Health Net insurance programs were significantly underperforming, which led to the need to increase reserves to offset losses caused by these programs; that Centene overstated the financial prospects of Health Net; and that as a result of the above, the Company's statements its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161117006444/en/

Copyright Business Wire 2010

If you liked this article you might like

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Why Centene Is One of Jim Cramer's 'Absolute Favorite Stocks'

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

A Regular Winning Trade Becomes Roadkill in Market Meltdown

A Regular Winning Trade Becomes Roadkill in Market Meltdown

It's a Flash Sale!: Cramer's 'Mad Money' Recap (Wednesday 1/31/18)

It's a Flash Sale!: Cramer's 'Mad Money' Recap (Wednesday 1/31/18)

Jim Cramer: Breaking Down the State of the Union in Rhetoric Per Share

Jim Cramer: Breaking Down the State of the Union in Rhetoric Per Share